Clinical Trial Update: Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study) [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating rosuvastatin plus enoxaparin for thromboprophylaxis after ovarian cancer surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CRESTOR (Rosuvastatin)
• Lovenox (enoxaparin)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED